Effectiveness of Recombinant Human Growth Hormone (rhGH) in the Treatment of Patients with Cystic Fibrosis
What To Discuss With Your Patients and Their Caregivers
When considering rhGH treatment for patients with CF, conversations with patients and their caregivers should include these concepts: that the evidence about benefits and harms of rhGH treatment for patients with CF is limited; whether the potential for reduced hospitalizations is applicable for the individual patient; whether there are concerns for the individual patient about long-term effects on diabetes and cancer risks; and the values and preferences of patients and caregivers concerning rhGH injections.
Keywords: decisionmaking | caregiver | values | preferences | patient | cystic fibrosis | CF | rhGH | recombinant human growth hormone | human growth hormone | HGH
- Phung OJ, Coleman CI, Baker EL, et al. Effectiveness of Recombinant Human Growth Hormone (rhGH) in the Treatment of Patients With Cystic Fibrosis. AHRQ Comparative Effectiveness Review No. 23 (Prepared by University of Connecticut-Hartford Hospital Evidence-based Practice Center under Contract No. 290-2007-10067-I). Rockville, MD: Agency for Healthcare Research and Quality; October 2010. AHRQ Publication No. 11-EHC003-EF.
Your slide tray is being processed.